Shares of Celgene Has Risen Above Previous 52-Week High
Shares of Celgene (NASDAQ:CELG) traded at a new 52-week high today of $96.85. So far today approximately 3.8 million shares have been exchanged, as compared to an average 30-day volume of 4.8 million shares.
Celgene share prices have moved between a 52-week high of $96.85 and a 52-week low of $66.85 and are now trading 43% above that low price at $95.64 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.4%.
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Potential upside of 10.2% exists for Celgene, based on a current level of $95.64 and analysts' average consensus price target of $105.43. The stock should discover initial support at its 50-day moving average (MA) of $92.32 and subsequent support at its 200-day MA of $82.57.
SmarTrend is monitoring the recent change of momentum in Celgene. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Celgene in search of a potential trend change.
Keywords: 52 week high/lows Celgene